ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) Stock Price & Overview
NASDAQ:ANPC • US03635R2067
Current stock price
The current stock price of ANPC is 4.37 USD. Today ANPC is down by -5.41%. In the past month the price decreased by -23.5%. In the past year, price decreased by -27.14%.
ANPC Key Statistics
- Market Cap
- 180.612M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -13.38
- Dividend Yield
- N/A
ANPC Stock Performance
ANPC Stock Chart
ANPC Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ANPC. When comparing the yearly performance of all stocks, ANPC is a bad performer in the overall market: 88.38% of all stocks are doing better.
ANPC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ANPC. Both the profitability and financial health of ANPC have multiple concerns.
ANPC Earnings
ANPC Forecast & Estimates
7 analysts have analysed ANPC and the average price target is 8.16 USD. This implies a price increase of 86.73% is expected in the next year compared to the current price of 4.37.
ANPC Groups
Sector & Classification
ANPC Financial Highlights
Over the last trailing twelve months ANPC reported a non-GAAP Earnings per Share(EPS) of -13.38. The EPS increased by 29.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ANPC Ownership
ANPC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 398.492B | ||
| AMGN | AMGEN INC | 16.04 | 198.265B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 180.267B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 121.459B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.932B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 42.071B | ||
| INSM | INSMED INC | N/A | 30.073B | ||
| BIIB | BIOGEN INC | 11.29 | 27.136B | ||
| NTRA | NATERA INC | N/A | 26.973B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.353B | ||
| MRNA | MODERNA INC | N/A | 21.086B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.713B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.84B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ANPC
Company Profile
Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. The company is headquartered in Lishui, Zhejiang and currently employs 89 full-time employees. The company went IPO on 2020-01-30. The firm markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The firm have established two clinical laboratories in China and one clinical laboratory in the United States. The firm is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.
Company Info
IPO: 2020-01-30
ANPAC BIO-MEDICAL SCIENC-ADR
801 Bixing Street, Bihu County
Lishui ZHEJIANG 323006 CN
CEO: Chris Chang Yu
Employees: 89
Phone: 8657820516666.0
ANPAC BIO-MEDICAL SCIENC-ADR / ANPC FAQ
What does ANPC do?
Anpac Bio-Medical Science Co., Ltd., is a biotechnology company. The company is headquartered in Lishui, Zhejiang and currently employs 89 full-time employees. The company went IPO on 2020-01-30. The firm markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The firm have established two clinical laboratories in China and one clinical laboratory in the United States. The firm is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.
What is the stock price of ANPAC BIO-MEDICAL SCIENC-ADR today?
The current stock price of ANPC is 4.37 USD. The price decreased by -5.41% in the last trading session.
Does ANPAC BIO-MEDICAL SCIENC-ADR pay dividends?
ANPC does not pay a dividend.
What is the ChartMill rating of ANPAC BIO-MEDICAL SCIENC-ADR stock?
ANPC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists ANPC stock?
ANPC stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.38).
Can you provide the number of employees for ANPAC BIO-MEDICAL SCIENC-ADR?
ANPAC BIO-MEDICAL SCIENC-ADR (ANPC) currently has 89 employees.